ARTICLE | Clinical News
Pollinex Quattro Birch: Phase IIb started
October 5, 2015 7:00 AM UTC
Allergy Therapeutics began a double-blind, placebo-controlled, dose-ranging, European Phase IIb trial to evaluate 6 dose regimens of Pollinex Quattro Birch in 350 patients. ...